missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ eRF1 Polyclonal Antibody

Description
Recommended positive controls: Neuro 2A, C8D30, NIH-3T3, Raw264.7, C2C12, PC-12, Rat2. Predicted reactivity: Mouse (100%), Rat (100%), Dog (100%), Rabbit (100%), Rhesus Monkey (100%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Termination of protein biosynthesis and release of the nascent polypeptide chain are signaled by the presence of an in-frame stop codon at the aminoacyl site of the ribosome. The process of translation termination is universal and is mediated by protein release factors.
Specifications
Specifications
| Antigen | eRF1 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.91 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 |
| Gene | ETF1 |
| Gene Accession No. | P62495, Q5U2Q7, Q8BWY3 |
| Gene Alias | AI463371; D5S1995; D6Ertd109e; ERF; ERF1; ETF1; Eukaryotic peptide chain release factor subunit 1; eukaryotic release factor 1; eukaryotic translation termination factor 1; polypeptide chain release factor 1; protein Cl1; RF1; sup45 (yeast omnipotent suppressor 45) homolog-like 1; SUP45L1; TB3-1 |
| Gene Symbols | ETF1 |
| Show More |